이산화탄소(CO2) 인큐베이터 시장 : 시장 기회, 성장 촉진요인, 산업 동향 분석, 예측(2025-2034년)

The Global Carbon Dioxide Incubators Market was valued at USD 792.7 million in 2024 and is projected to expand at a 5.9% CAGR from 2025 to 2034. Market growth is primarily driven by increasing research activities in biotechnology, pharmaceuticals, and medical sciences. The need for stable incubation environments in cell culture, drug testing, and clinical research is fueling the demand for advanced CO2 incubators. Companies and research institutions seek high-precision solutions to maintain controlled conditions essential for reliable results. Expanding R&D investments in emerging markets, advancements in healthcare infrastructure, and rising interest in in vitro applications are further accelerating market expansion. Additionally, continuous technological developments, including automation and sensor innovations, are enhancing efficiency and performance, contributing to sustained market growth.

Carbon dioxide incubators are designed to maintain optimal conditions for biological cultures, ensuring precise control over temperature, humidity, and CO2 levels. Based on product type, the market includes water jacket, air jacket, and direct heat CO2 incubators. Water jacket CO2 incubators led the market in 2024, generating USD 313 million in revenue. Their ability to maintain consistent temperature regulation makes them a preferred choice for long-term research. These incubators reduce temperature fluctuations, ensuring the stability required for sensitive scientific applications.

By capacity, the market is divided into three segments: below 100 liters, 100-200 liters, and above 200 liters. The 100-200 liters category is projected to experience a 6.4% CAGR, surpassing USD 687.2 million by 2034. This segment dominates due to its versatility in laboratories, providing ample space for multiple culture vessels without requiring excessive room. Its balance of capacity and efficiency makes it an attractive option across research applications.

In terms of application, the market covers laboratory research, in vitro applications, and other scientific uses. Laboratory research is expected to maintain its dominant position, growing at a 6.4% CAGR and exceeding USD 760.7 million by 2034. The rising demand for controlled environments in genetic, microbiological, and cellular research is increasing reliance on CO2 incubators. As global interest in genomics, biotechnology, and regenerative medicine grows, laboratories require these systems to sustain optimal conditions for biological studies.

Sensor technology plays a crucial role in maintaining CO2 levels within incubators. The market is categorized into infrared (IR) and thermal conductivity (TC) CO2 incubators, among others. IR CO2 incubators are anticipated to achieve a 6.5% CAGR, surpassing USD 863.6 million by 2034. Their high accuracy and rapid response capabilities ensure stable conditions for cell cultures, making them the preferred choice in research and medical applications.

By end use, the market includes biotechnology and pharmaceutical companies, academic institutions, and clinical laboratories. Biotechnology and pharmaceutical firms accounted for 39.3% of total revenue in 2024 due to their extensive use in drug development, genetic studies, and clinical trials.

The U.S. market reached USD 169.3 million in 2024 and is expected to grow at a 5.6% CAGR through 2034, driven by its advanced healthcare sector, research infrastructure, and ongoing medical innovations.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing adoption of CO2 incubators in cell culture and stem cell research
    • 3.2.1.2 Rising prevalence of chronic diseases and demand for regenerative medicine
    • 3.2.1.3 Advancements in incubator technology
    • 3.2.1.4 Growth in biopharmaceutical and vaccine production
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of advanced CO2 incubators
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Gap analysis
• 3.7 Porter's analysis
• 3.8 PESTEL analysis
• 3.9 Future market trends
• 3.10 Value chain analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Water jacket carbon dioxide incubators
• 5.3 Air jacket carbon dioxide incubators
• 5.4 Direct heat carbon dioxide incubators
• 5.5 Other product types

Chapter 6 Market Estimates and Forecast, By Capacity, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 100 – 200 liters
• 6.3 Below 100 liters
• 6.4 Above 200 liters

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Laboratory research
• 7.3 In vitro fertilization (IVF)
• 7.4 Cancer research
• 7.5 Other applications

Chapter 8 Market Estimates and Forecast, By Sensor Technology, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Infrared (IR) CO2 incubators
• 8.3 Thermal conductivity (TC) CO2 incubators
• 8.4 Other sensor technologies

Chapter 9 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 Biotechnology and pharmaceutical companies
• 9.3 Academic and research institutions
• 9.4 Clinical laboratories
• 9.5 Other end users

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 10.1 Key trends
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Netherlands
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 South Korea
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Argentina
• 10.6 Middle East and Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 UAE

Chapter 11 Company Profiles

• 11.1 avantor
• 11.2 BINDER
• 11.3 CARON SCIENTIFIC
• 11.4 ESCO
• 11.5 HYLAND
• 11.6 Labotect
• 11.7 memmert
• 11.8 NUAIRE
• 11.9 phcbi
• 11.10 SHELDON MANUFACTURING
• 11.11 Thermo Fisher